Total investments 18
Average round size 
$115M
The average size of a deal this fund participated in
Portfolio companies 12
Rounds per year 3.00
Lead investments 4
Follow on index
0.33How often the fund supports its portfolio startups at next rounds
Exits 1
Key employees Soon
Boston, Massachusetts, United States Funds with similar focus
Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:
Look at other 50 related and similar funds Collapse list ↓
| Fund Name | Location |
| Anniston Capital | New York, New York, United States |
| ClearVue Partners | China, Shanghai, Shanghai |
| Fluid Vehicle Owners | - |
| Galileo Ventures | China, Shanghai |
| Harbright Ventures | North Carolina, Raleigh, United States |
| Healthcare Co-op | California, San Francisco, United States |
| HY Capital | Changning, China, Shanghai |
| Montiko GmbH | Baden-Wurttemberg, Germany, Karlsruhe |
| NatWest Markets | England, London, United Kingdom |
| Paraca | Japan, Tokyo |
| Praetorian Financial Group (PFG) | New York, New York, United States |
| Prime Holdings | - |
| Promus Equity Partners | Chicago, Illinois, United States |
| Qianhai Daren | China, Guangdong, Shenzhen |
| Shenzhen Qianhai Rengong Zhineng Liuhao Touzi | China, Guangdong, Shenzhen |
| Space Expedition Corporation (SXC) | Amsterdam, Noord-Holland, The Netherlands |
| Tribune Ventures | Chicago, Illinois, United States |
| UniqueLab | Japan, Tokyo |
| UST | Aliso Viejo, California, United States |
| Wellspring Investments | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Autobahn Therapeutics | $100M | 24 Jul 2024 | San Diego, California, United States | ||
Metsera | $290M | 18 Apr 2024 | New York, New York, United States | ||
Nvelop Therapeutics | $100M | 25 Sep 2023 | Cambridge, Massachusetts, United States | ||
Magnet Biomedicine | $50M | 19 Sep 2023 | Cambridge, Massachusetts, United States | ||
Myeloid Therapeutics | $73M | 18 May 2023 | Cambridge, Massachusetts, United States | ||
Orbital Therapeutics | $270M | 26 Apr 2023 | - | ||
Chroma Medicine | $135M | 01 Mar 2023 | Cambridge, Massachusetts, United States | ||
Neumora Therapeutics | $112M | 11 Oct 2022 | Watertown, Massachusetts, United States | ||
Orbital Therapeutics | 07 Sep 2022 | - |
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
To post a comment or write a complain, please sign in with LinkedIn
Review
- No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Do you represent Newpath Management?
Get access to manage this page
Found incorrect info? Let us know!
Total investments 18
Average round size 115M
Rounds per year 3.00
Peak activity year 2021
Lead investments 4
Follow on index 0.33
Exits 1
Group Appearance index 1.00
Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Autobahn Therapeutics | $100M | 24 Jul 2024 | San Diego, California, United States | ||
Metsera | $290M | 18 Apr 2024 | New York, New York, United States | ||
Nvelop Therapeutics | $100M | 25 Sep 2023 | Cambridge, Massachusetts, United States | ||
Magnet Biomedicine | $50M | 19 Sep 2023 | Cambridge, Massachusetts, United States | ||
Myeloid Therapeutics | $73M | 18 May 2023 | Cambridge, Massachusetts, United States | ||
Orbital Therapeutics | $270M | 26 Apr 2023 | - | ||
Chroma Medicine | $135M | 01 Mar 2023 | Cambridge, Massachusetts, United States | ||
Neumora Therapeutics | $112M | 11 Oct 2022 | Watertown, Massachusetts, United States | ||
Orbital Therapeutics | 07 Sep 2022 | - |
